ATBECHDEDKESFRGBGRITLILUNLSEMCPTIESILTLVFIROMKCYAL..................................................JDIM360 Ver 2.40 (30 Jan 2013) - 2999001/0The file contains technical information submitted after the application was filed and not included in this specification1685839CORRECTED EUROPEAN PATENT SPECIFICATIONB8B120130626W184deBibliographieenBibliographyfrBibliographieEP06111805.5199812222006032820080219enenen68480 P19971222US2013062620132620060802200631201304102013152012110520130626201326A61K 31/485 20060101AFI20060627BHEP A61P 25/36 20060101ALI20060627BHEP dePeroral zu verabreichende Arzneiform enthaltend eine Kombination von einem Opioid-Agonisten und einem Opioid- AntagonistenenPharmaceutical oral dosage form comprising a combination of an opioid agonist and opioid antagonistfrFormulation pharmaceutique pour administration orale comprenant en combinaison un agoniste et un antagoniste des récepteurs opiacésWO-A-97/33566US-A- 4 457 933US-A- 4 582 835US-A- 4 661 492US-A- 5 512 57898964853.010419871998122210179026.9226656420100923Kaiko, Robert F. 10 Norfield Woods RoadWeston, CT 06883USColucci, Robert D. 28 Clearview DriveNewtown, CT 06482USEURO-CELTIQUE S.A.101031225E 8814 / HG2, avenue Charles de Gaulle1653 LuxembourgLUGlas, Holger100051941Maiwald Patentanwalts GmbH Elisenhof Elisenstrasse 380335 MünchenDEATBECHCYDEDKESFIFRGBGRIEITLILUMCNLPTSEAL20060328LT20060328LV20060328MK20060328RO20060328SI2006032820060802200631